Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC
| SLAYBACK PHARMA LLC |
| EAGLE PHARMACEUTICALS INC. |
| 19-1924 |
| May 24, 2019 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC
|
| EAGLE PHARMACEUTICALS INC. v. SLAYBACK PHARMA LLC |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 5, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 REMINDER : All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [619328] [JAL] [Entered: 07/05/2019 03:47 PM] |
| Filing 11 Filing fee paid in the United States District Court for the District of Delaware on 05/23/2019. [613221] [JAL] [Entered: 06/11/2019 03:18 PM] |
| Filing 10 Docketing Statement for the Appellee Slayback Pharma LLC. Service: 06/07/2019 by email. [612583] [19-1924] [James Barabas] [Entered: 06/07/2019 05:38 PM] |
| Filing 9 Certificate of Interest for the Appellee Slayback Pharma LLC. Service: 06/07/2019 by email. [612578] [19-1924] [James Barabas] [Entered: 06/07/2019 05:34 PM] |
| Filing 8 Entry of appearance for James P. Barabas as principal counsel for Appellee Slayback Pharma LLC. Service: 06/07/2019 by email. [612576] [19-1924] [James Barabas] [Entered: 06/07/2019 05:31 PM] |
| Filing 7 Entry of appearance for Marc N. Zubick as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612497] [19-1924] [Marc Zubick] [Entered: 06/07/2019 03:16 PM] |
| Filing 6 Entry of appearance for Kenneth G. Schuler as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612490] [19-1924] [Kenneth Schuler] [Entered: 06/07/2019 03:13 PM] |
| Filing 5 Entry of appearance for Gabriel K. Bell as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612486] [19-1924] [Gabriel Bell] [Entered: 06/07/2019 03:10 PM] |
| Filing 4 Docketing Statement for the Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612480] [19-1924] [Daniel Brown] [Entered: 06/07/2019 03:07 PM] |
| Filing 3 Certificate of Interest for the Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612477] [19-1924] [Daniel Brown] [Entered: 06/07/2019 03:05 PM] |
| Filing 2 Entry of appearance for Daniel G. Brown as principal counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612475] [19-1924] [Daniel Brown] [Entered: 06/07/2019 03:02 PM] |
| Filing 1 Appeal docketed. Received: 05/23/2019. [609661] Fee is due on 06/07/2019. Entry of Appearance is due 06/07/2019. Certificate of Interest is due on 06/07/2019. Docketing Statement is due 06/07/2019. Appellant's brief is due 07/23/2019. [JAL] [Entered: 05/24/2019 04:05 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
